Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Jochen Lorch

Clinical trials sponsored by Jochen Lorch, explained in plain language.

Trials to join now! 1

New hope for Hard-to-Treat thyroid cancer: drug XL092 enters human trials

Disease control Recruiting now

This phase 2 trial tests a drug called XL092 in 33 people with advanced thyroid cancer that has stopped responding to radioiodine therapy. XL092 works by blocking a protein that helps cancer cells grow. The study aims to see if the drug can slow or stop cancer progression.

Phase 2 • Sponsor: Jochen Lorch • Aim: Disease control

Last updated Jun 28, 2026 00:00 UTC